The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241
Howe, D.; Lynas, C.
Haematologica 86(6): 563-569
2001
ISSN/ISBN: 0390-6078 PMID: 11418363 Document Number: 534718
The cyclin D1 gene, CCND1, is alternatively spliced to produce transcripts . In the small cohort studied, the polymorphism did not appear to affect the prognosis of the patients with MCL.
Document emailed within 1 workday
Related Documents
Li, H.; Lahti, J.M.; Kidd, V.J. 1996: Alternatively spliced cyclin C mRNA is widely expressed, cell cycle regulated, and encodes a truncated cyclin box Oncogene 13(4): 705-712Papadopoulou, E.; Anagnostopoulos, K.; Tripsianis, G.; Tentes, I.; Kakolyris, S.; Galazios, G.; Sivridis, E.; Simopoulos, K.; Kortsaris, A. 2008: Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism Neoplasma 55(3): 229-238
Fu, J.; Jiang, Y.-g.; Bin, X.-n.; Chen, X.-m. 2006: Study on E-cadherin, Cyclin D1 and Cyclin e expression in anti-malignant transformation by chlorophyllin Wei Sheng Yan Jiu 35(6): 678-681
Allam, M.M.; Abd El Moneim, E.; Hassouna, M.M.; El Jaky, A.; Zaghlah, H. 2009: Levels of chemokine receptors expressed on peripheral blood T lymphocytes of Egyptian patients with hepatocellular carcinoma Egyptian Journal of Immunology 16(1): 17-25
Tam, S.W.; Theodoras, A.M.; Shay, J.W.; Draetta, G.F.; Pagano, M. 1994: Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression Oncogene 9(9): 2663-2674
Tovey, M.G.; Content, J.; Gresser, I.; Gugenheim, J.; Blanchard, B.; Guymarho, J.; Poupart, P.; Gigou, M.; Shaw, A.; Fiers, W. 1988: Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals Journal of Immunology 141(9): 3106-3110
Songia, S.; Mortellaro, A.; Taverna, S.; Fornasiero, C.; Scheiber, E.A.; Erba, E.; Colotta, F.; Mantovani, A.; Isetta, A.M.; Golay, J. 1997: Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets Journal of Immunology 158(8): 3987-3995
Asundi, V.; Cowan, K.; Matzura, D.; Wagner, W.; Dreher, K.L. 1990: Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells European Journal of Cell Biology 52(1): 98-104
Heiniger, H.J. 1981: Cholesterol and its biosynthesis in normal and malignant lymphocytes Cancer Research 41(9 Pt 2): 3792-3794
Alvarado-de la Barrera, C.; Bahena, S.; Llorente, L.; Martínez-Castillo, A.; Alarcón-Segovia, D.; Cabral, A.R. 1998: Beta2-glycoprotein-I mRNA transcripts are expressed by hepatocytes but not by resting or activated human endothelial cells Thrombosis Research 90(5): 239-243
D'Onofrio, M.; de Grazia, U.; Morrone, S.; Cuomo, L.; Spinsanti, P.; Frati, L.; Gulino, A.; Ragona, G. 2000: Expression of neurotrophin receptors in normal and malignant B lymphocytes European Cytokine Network 11(2): 283-291
Pierce, G.E.; DeVald, B.L. 1975: Effects of human lymphocytes on cultured normal and malignant cells Cancer Research 35(7): 1830-1839
Reale, M.A.; Hu, G.; Zafar, A.I.; Getzenberg, R.H.; Levine, S.M.; Fearon, E.R. 1994: Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues Cancer Research 54(16): 4493-4501
Bilous, N.I.; Abramenko, I.V.; Chumak, A.A.; Dyagil, I.S.; Martіna, Z.V. 2014: TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia Experimental Oncology 36(4): 258-261
Malisic, E.; Jankovic, R.; Slavkovic, D.; Milovic-Kovacevic, M.; Radulovic, S. 2010: P53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia Journal of BUON: Official Journal of the Balkan Union of Oncology 15(1): 101-106
Tseng, H-Chang.; Tsai, M-Hsui.; Chiu, C-Fang.; Wang, C-Hsing.; Chang, N-Wen.; Huang, C-Yang.; Tsai, C-Wen.; Liang, S-Yun.; Wang, C-Li.; Bau, D-Tian. 2008: Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan Anticancer Research 28(3a): 1687-1691
Dybikowska, A.; Dettlaff, A.; Konopa, K.; Podhajska, A. 2000: P53 codon 72 polymorphism in cervical cancer patients and healthy women from Poland Acta Biochimica Polonica 47(4): 1179-1182
Jacob, A.N.; Kandpal, G.; Kandpal, R.P. 1996: Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12 Oncogene 13(1): 213-221
Hussain, R.; Khaliq, S.; Raza, S.Mohsin.; Khaliq, S.; Lone, K.Pervaiz. 2018: Association of TP53 codon 72 polymorphism in women suffering from endometriosis from Lahore, Pakistan Jpma. Journal of the Pakistan Medical Association 68(2): 224-230
Smith, M.A.C.; Silva, M.D.A.; Cendoroglo, M.S.; Ramos, L.R.; Araujo, L.M.Q.; Labio, R.W.; Burbano, R.R.; Chen, E.S.; Payão, S.L.M. 2007: TP53 codon 72 polymorphism as a risk factor for cardiovascular disease in a Brazilian population Brazilian Journal of Medical and Biological Research 40(11): 1465-1472